Before I knew I had metastatic Neuroendocrine Tumours, I was diagnosed with Iron Deficiency Anaemia by my local GP after two low haemoglobin results (classic sign as haemoglobin is a building block of iron). He referred me to the anaemia clinic at my local hospital. I never made it that far as I often to see a specialist privately, got a CT scan and boom! I was then treated for NET as per that guideline and my haemoglobin went back to normal although I am consistently borderline. I am regularly screened for anaemia/iron deficiency via both haemoglobin and an iron panel. So following a flurry of spotlights on the key vitamins at risk for NET, I wanted to cover some of the minerals (micronutrients) – so why not Iron.
A general‑population overview with NET‑specific considerations where relevant.
What is Iron?
Iron is an essential mineral required for oxygen transport, energy production, and cellular metabolism. It exists in two main dietary forms:
- Haem iron — from animal sources; highly bioavailable
- Non‑haem iron — from plant sources; absorption varies with diet and gut health
Iron is stored mainly in the liver, spleen, and bone marrow. Because the body has no active excretion pathway, iron balance depends entirely on absorption and losses — making deficiency relatively common.
What does Iron do?
- Forms haemoglobin for oxygen transport
- Supports myoglobin in muscle tissue
- Enables mitochondrial energy production
- Supports immune function
- Participates in DNA synthesis
Deficiency
Iron deficiency is the most common micronutrient deficiency worldwide. It may result from:
- Inadequate intake
- Chronic inflammation
- Malabsorption
- Chronic blood loss
- Gastrointestinal disease
Functional iron deficiency occurs when iron stores are adequate but unavailable due to inflammation‑driven hepcidin elevation.
Symptoms
- Fatigue and reduced exercise tolerance
- Shortness of breath
- Restless legs
- Hair loss
- Cold intolerance
- Pale skin
- Pagophagia (ice craving)
- Brittle nails / koilonychia
- Cognitive fog / reduced concentration
Iron deficiency anaemia
Occurs when iron stores are exhausted and haemoglobin production falls.
Testing
Common tests include:
- Serum ferritin — reflects iron stores; low ferritin indicates deficiency unless inflammation is present
- Transferrin saturation (TSAT) — indicates available iron; particularly useful in chronic disease or inflammation
- Serum iron — fluctuates; less useful alone
- Full blood count (FBC) — microcytic anaemia in deficiency
Inflammation can raise ferritin, masking deficiency.
Sources & Absorption
- Haem iron — red meat, poultry, fish
- Non‑haem iron — legumes, whole grains, nuts, seeds, leafy greens
Absorption is enhanced by Vitamin C and inhibited by:
- Tea/coffee (polyphenols)
- Calcium
- Phytates (whole grains, legumes)
- Some medications (PPIs)
Iron is best absorbed on an empty stomach, though taking it with food may reduce side effects.
Supplements & Toxicity
Supplements
- Ferrous salts (sulfate, fumarate, gluconate) — widely used, effective
- Polysaccharide iron — gentler on the stomach
- IV iron — for severe deficiency or malabsorption
Side effects of oral iron include nausea, constipation, and dark stools.
Emerging evidence suggests that alternate‑day dosing may improve absorption and reduce side effects.
Toxicity
Iron overload is uncommon without:
- Hereditary haemochromatosis
- Repeated transfusions
- Excessive supplementation
Symptoms include joint pain, fatigue, liver dysfunction, and skin pigmentation.
NET‑Specific Considerations
Iron deficiency is common in people with NETs due to several mechanisms:
- Chronic diarrhoea reducing nutrient absorption
- Small bowel NETs or resection impairing iron uptake It primarily occurs due to chronic, occult (hidden) blood loss from fragile tumour tissues in the stomach, duodenum, or small intestine. Malabsorption can also contribute.
- Duodenal NETs (duodenum/jejunum)
- Gastric NETs or atrophic gastritis reducing acid → impaired iron absorption
- Chronic bleeding (e.g., from small bowel lesions)
- Inflammation causing functional iron deficiency (hepcidin‑mediated)
- Mesenteric fibrosis affecting motility or causing intermittent bleeding
- SIBO contributing to both iron and B12 deficiency
Iron deficiency may coexist with B12 deficiency, especially after ileal resection or in SIBO.
See my coverage of Vitamin B12 (Cobalamin)
The 2025 ESMO review highlights that patients with NETs frequently experience micronutrient deficiencies due to malabsorption, diarrhoea, and treatment effects. While the paper focuses on fat‑soluble vitamins and B‑vitamins, it also notes that iron deficiency is common in NET patients, particularly those with small bowel involvement, chronic bleeding, or long‑term somatostatin analogue therapy. NANETS nutritional guidance (2024) similarly identifies iron deficiency as a recurrent issue in small bowel NETs.
References Used
- NHS Iron Guidance
- NIH Office of Dietary Supplements – Iron Fact Sheet
- ESMO – Reducing deficiencies of fat-soluble vitamins, vitamin B12, and vitamin B3 in patients with neuroendocrine tumors treated with somatostatin analogues – L.D. de Hosson, S. Bunskoek, J. Stelwagen, B. Sijtema, S. Huitema, M. van Faassen, G.H. de Bock, D.J.A. de Groot, M.J.E. Campmans-Kuijpers, I.P. Kema, E.G.E. de Vries, A.M.E. Walenkamp, Volume 4, 2025, 100032, ISSN 3050-4619, https://doi.org/10.1016/j.esmorc.2025.100032. (https://www.sciencedirect.com/science/article/pii/S3050461925000310)
Disclaimer
I am not a doctor or any form of medical professional, practitioner or counsellor. None of the information on my website, or linked to my website(s), or conveyed by me on any social media or presentation, should be interpreted as medical advice given or advised by me.
Neither should any post or comment made by a follower or member of my private group be assumed to be medical advice, even if that person is a healthcare professional.
Please also note that mention of a clinical service, trial/study or therapy does not constitute an endorsement of that service, trial/study or therapy by Ronny Allan, the information is provided for education and awareness purposes and/or related to Ronny Allan’s own patient experience. This element of the disclaimer includes any complementary medicine, non-prescription over the counter drugs and supplements such as vitamins and minerals.
Click here and answer all questions to join my private Facebook group
Check out my Glossary of Terms – click here
Please Share this post for Neuroendocrine Cancer awareness and to help another patient
PRRT – The Sequel? Alpha-emitter PRRT for Neuroendocrine Tumours (NET)October 26, 2024Clinical Trials and Research
The Classification, Grading and Staging of Neuroendocrine Neoplasms (incorporating WHO 2026 classification changes)March 11, 2024Patient Advocacy
Clinical Trials PRRT: From 177Lu to 225Ac: The DOTA-LM3 Antagonist JourneyJune 24, 2026Clinical Trials and Research
Curium – New Drug Application for 'Radioequivalent' Lutetium 177 Dotatate PRRTJuly 11, 2024Patient AdvocacyDiscover more from Ronny Allan - Living with Neuroendocrine Cancer
Subscribe to get the latest posts sent to your email.






